340 related articles for article (PubMed ID: 22066465)
21. Two-dimensional statistical recoupling for the identification of perturbed metabolic networks from NMR spectroscopy.
Blaise BJ; Navratil V; Domange C; Shintu L; Dumas ME; Elena-Herrmann B; Emsley L; Toulhoat P
J Proteome Res; 2010 Sep; 9(9):4513-20. PubMed ID: 20590164
[TBL] [Abstract][Full Text] [Related]
22. Actinin-4 expression in primary and metastasized pancreatic ductal adenocarcinoma.
Welsch T; Keleg S; Bergmann F; Bauer S; Hinz U; Schmidt J
Pancreas; 2009 Nov; 38(8):968-76. PubMed ID: 19672209
[TBL] [Abstract][Full Text] [Related]
23. Urinary metabolite prognostic biomarker panel for pancreatic ductal adenocarcinomas.
Hipperson L; Hadden WJ; Nahm CB; Gill AJ; Samra JS; Dona A; Mittal A; Sahni S
Biochim Biophys Acta Gen Subj; 2021 Nov; 1865(11):129966. PubMed ID: 34329704
[TBL] [Abstract][Full Text] [Related]
24. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas.
Qi T; Han J; Cui Y; Zong M; Liu X; Zhu B
J Clin Pathol; 2008 Jan; 61(1):49-58. PubMed ID: 17412869
[TBL] [Abstract][Full Text] [Related]
25. (1)H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool.
Zira AN; Theocharis SE; Mitropoulos D; Migdalis V; Mikros E
J Proteome Res; 2010 Aug; 9(8):4038-44. PubMed ID: 20527959
[TBL] [Abstract][Full Text] [Related]
26. Cross-platform analysis of longitudinal data in metabolomics.
Nevedomskaya E; Mayboroda OA; Deelder AM
Mol Biosyst; 2011 Dec; 7(12):3214-22. PubMed ID: 21947311
[TBL] [Abstract][Full Text] [Related]
27. Untargeted LC-HRMS-Based Metabolomics for Searching New Biomarkers of Pancreatic Ductal Adenocarcinoma: A Pilot Study.
Ríos Peces S; Díaz Navarro C; Márquez López C; Caba O; Jiménez-Luna C; Melguizo C; Prados JC; Genilloud O; Vicente Pérez F; Pérez Del Palacio J
SLAS Discov; 2017 Apr; 22(4):348-359. PubMed ID: 27655283
[TBL] [Abstract][Full Text] [Related]
28. Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma.
Ben QW; Wang JC; Liu J; Zhu Y; Yuan F; Yao WY; Yuan YZ
Ann Surg Oncol; 2010 Aug; 17(8):2213-21. PubMed ID: 20162456
[TBL] [Abstract][Full Text] [Related]
29. Nuclear magnetic resonance-based metabonomics reveals strong sex effect on plasma metabolism in 17-year-old Scandinavians and correlation to retrospective infant plasma parameters.
Bertram HC; Duus JØ; Petersen BO; Hoppe C; Larnkjaer A; Schack-Nielsen L; Mølgaard C; Michaelsen KF
Metabolism; 2009 Jul; 58(7):1039-45. PubMed ID: 19411084
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus infection diagnosis using metabonomics.
Godoy MM; Lopes EP; Silva RO; Hallwass F; Koury LC; Moura IM; Gonçalves SM; Simas AM
J Viral Hepat; 2010 Dec; 17(12):854-8. PubMed ID: 20070502
[TBL] [Abstract][Full Text] [Related]
31. A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer.
Jobard E; Pontoizeau C; Blaise BJ; Bachelot T; Elena-Herrmann B; Trédan O
Cancer Lett; 2014 Feb; 343(1):33-41. PubMed ID: 24041867
[TBL] [Abstract][Full Text] [Related]
32. Metabonomic changes from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma in tissues from rats.
Wen S; Li Z; Feng J; Bai J; Lin X; Huang H
Cancer Sci; 2016 Jun; 107(6):836-45. PubMed ID: 27019331
[TBL] [Abstract][Full Text] [Related]
33. 1H NMR-based spectroscopy detects metabolic alterations in serum of patients with early-stage ulcerative colitis.
Zhang Y; Lin L; Xu Y; Lin Y; Jin Y; Zheng C
Biochem Biophys Res Commun; 2013 Apr; 433(4):547-51. PubMed ID: 23510994
[TBL] [Abstract][Full Text] [Related]
34. Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome.
Dessì A; Atzori L; Noto A; Visser GH; Gazzolo D; Zanardo V; Barberini L; Puddu M; Ottonello G; Atzei A; De Magistris A; Lussu M; Murgia F; Fanos V
J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 2():35-9. PubMed ID: 21767100
[TBL] [Abstract][Full Text] [Related]
35. Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor.
Barba I; Garcia-Ramírez M; Hernández C; Alonso MA; Masmiquel L; García-Dorado D; Simó R
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4416-21. PubMed ID: 20375324
[TBL] [Abstract][Full Text] [Related]
36. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
37. Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma.
Vizio B; Mauri FA; Prati A; Trivedi P; Giacobino A; Novarino A; Satolli MA; Ciuffreda L; Camandona M; Gasparri G; Bellone G
Oncol Rep; 2012 Jan; 27(1):69-76. PubMed ID: 21922151
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
[TBL] [Abstract][Full Text] [Related]
39. Fecal and urinary NMR-based metabolomics unveil an aging signature in mice.
Calvani R; Brasili E; Praticò G; Capuani G; Tomassini A; Marini F; Sciubba F; Finamore A; Roselli M; Marzetti E; Miccheli A
Exp Gerontol; 2014 Jan; 49():5-11. PubMed ID: 24184118
[TBL] [Abstract][Full Text] [Related]
40. Understanding metabolomic characteristics of pancreatic ductal adenocarcinoma by HR-MAS NMR detection of pancreatic tissues.
Wang S; Wen S; Guo P; Liu H; Feng J; Huang H
J Pharm Biomed Anal; 2020 Oct; 190():113546. PubMed ID: 32846403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
